Looking to reach U.S. consumers, a Belgian chocolate brand has launched a new website and package design for its namesake treats.

Scott Naturals is challenging consumers to use its line of hybrid paper products.

The U.S. subsidiary of India-based generic drug maker Hetero Drugs has appointed Konstantin Ostaficiuk as its president, Camber said.

Generic drug maker Mylan is suing the Food and Drug Administration in an effort to prevent Gurgaon, India-based competitor Ranbaxy Labs from launching its generic version of Pfizer’s cholesterol medication Lipitor, according to published reports.

The maker behind such brands as Goody and Sharpie has expanded its board of directors to 12 members.

Procter & Gamble announced the grand opening of its new plant in Box Elder, Utah, marking the first plant the company has built in four decades.

McNeil last week finalized the terms of a consent decree of permanent injunction with the Food and Drug Administration for manufacturing facilities operated by the McNeil Consumer Healthcare Division in Las Piedras, Puerto Rico; Fort Washington, Pa.; and Lancaster, Pa.

The Food and Drug Administration has approved biotech company Dendreon’s expansion of manufacturing capacity for an immunotherapy treatment for prostate cancer, Dendreon said Thursday.

Prestige Brands on Friday named Paul Hennessey VP operations.

Procter & Gamble is working toward making its sites LEED-certified as part of the company's long-term sustainability commitment.

Lansinoh Labs on Tuesday announced the acquisition of certain operational and manufacturing assets from En-Ko Electronic Control Systems in Izmir, Turkey. The acquisition will allow Lansinoh to directly control the manufacturing of the Lansinoh Affinity double electric breast pump, Lansinoh Affinity breast-milk storage bottles and Lansinoh ComfortFit flanges.

Irish biotech company Elan and German drug maker Boehringer Ingelheim will collaborate to develop and manufacture antibody-based medicines.